NEW YORK, NY / ACCESSWIRE / June 26, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Heron Therapeutics, Inc. (HRTX)
Class Period: October 31, 2018 to April 30, 2019
Lead Plaintiff Deadline: August 5, 2019
The complaint alleges that during the class period Heron Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls ("CMC") and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron's NDA for HTX-011; and (iii) as a result, Heron's public statements were materially false and misleading at all relevant times.
Get additional information about the HRTX lawsuit: http://www.kleinstocklaw.com/pslra-1/heron-therapeutics-inc-loss-submission-form?id=2103&from=1
Cloudera, Inc. (CLDR)
Class Period: April 28, 2017 to June 5, 2019
Lead Plaintiff Deadline: August 6, 2019
The lawsuit alleges Cloudera, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Cloudera was finding it increasingly difficult to identify large enterprises interested in adopting the Company's Hadoop-based platform; (ii) Cloudera needed to expend an increasing amount of capital on sales and marketing activities to generate new revenues, even as new revenue opportunities were diminishing; and (iii) Cloudera had materially diminished sales opportunities and prospects and could not generate annual positive cash flows.
Get additional information about the CLDR lawsuit: http://www.kleinstocklaw.com/pslra-1/cloudera-inc-loss-submission-form?id=2103&from=1
Anheuser-Busch Inbev Sa/Nv (BUD)
Class Period: March 1, 2018 to October 24, 2018
Lead Plaintiff Deadline: August 20, 2019
According to the filed complaint, Defendants issued a steady stream of materially false and misleading reassurances about Anheuser Busch's deleveraging efforts, cost cutting measures, EBITDA growth, the sufficiency of its liquidity and its debt maturity profile during the Class Period. These positive statements by Defendants created a false impression and materially misled investors about the Company's finances, including the sustainability of Anheuser-Busch's dividends. Once Defendants chose to speak about Anheuser-Busch's finances, they had a duty to speak completely and truthfully, including speaking about those factors that were then having a material adverse effect on the Company's deleveraging efforts.
Get additional information about the BUD lawsuit: http://www.kleinstocklaw.com/pslra-1/anheuser-busch-inbev-sa-nv-loss-submission-form?id=2103&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: The Klein Law Firm
View source version on accesswire.com: